✨ Ask AkshayaAI anything about this stock — instant AI answers. Try the AI assistant →
AkshayaAIStocks › CME

CME — CME Group Inc

AI Signal & Stock Analysis · Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for CME is Strong ↑; the stock is at $269.95 (+1.03% today); neutral (RSI 64); technical trend is down-trend; news sentiment is positive.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

AI signal (Strength)Strong ↑
Price$269.95
Change today+1.03%
RSI (14)64.23
Relative volume0.34
Composite (RMTPGV) score🔒 members
Market cap$97.1B
Forward P/E20.87
52-week high-16.5% away
52-week low+23.5% above
Technical trendDown-trend (since 2024-01-26)
News sentimentPositive
SectorFinancial-Markets
Next earnings7/22/2026 8:30:00 AM

What's driving the signal

🔒 AkshayaAI factor scores — Momentum, Technical, Performance, Growth, Volatility and the composite RMTPGV score are members-only. Sign in free to see the full breakdown →
Ask a follow-up or get live data on CME → open the AI assistant

Frequently asked about CME

What is AkshayaAI's signal for CME today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns CME (CME Group Inc) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is CME overbought or oversold right now?

CME's RSI is neutral (RSI 64). A reading above 70 is typically considered overbought and below 30 oversold.

Where is CME in its 52-week range?

CME is trading about 16% below its 52-week high and 24% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is CME's next earnings date?

CME's next earnings date is 7/22/2026 8:30:00 AM.

What sector is CME in?

CME is classified under Financial-Markets in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.

🤖

Ask AkshayaAI about CME

Instant, data-backed answers — free to try.